Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marla Weetall

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 15, 2015
Discovery of 2-(4-sulfonamidophenyl)-indole 3-carboxamides as potent and selective inhibitors with broad hepatitis C virus genotype activity targeting HCV NS4BNanjing Zhang, Anthony Turpoff, Xiaoyan Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2019
Effective Delivery of a Microtubule Polymerization Inhibitor Synergizes with Standard Regimens in Models of Pancreatic Ductal AdenocarcinomaJaime A Eberle-Singh, Irina Sagalovskiy, H Carlo Maurer, et al.
Human Molecular Genetics|August 9, 2021
SMN protein is required throughout life to prevent spinal muscular atrophy disease progressionXin Zhao, Zhihua Feng, Nicole Risher, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2015
6-(Azaindol-2-yl)pyridine-3-sulfonamides as potent and selective inhibitors targeting hepatitis C virus NS4BGuangming Chen, Hongyu Ren, Nanjing Zhang, et al.
Cancer Science|October 10, 2020
Efficacy of the novel tubulin polymerization inhibitor PTC-028 for myelodysplastic syndromeCheng Zhong, Kensuke Kayamori, Shuhei Koide, et al.
Plos One|December 20, 2016
Discovery of Novel Small Molecule Inhibitors of VEGF Expression in Tumor Cells Using a Cell-Based High Throughput Screening PlatformLiangxian Cao, Marla Weetall, Jenelle Bombard, et al.
Frontiers in Oncology|February 28, 2022
Emvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid LeukemiaArthur Branstrom, Liangxian Cao, Bansri Furia, et al.
Journal of Medicinal Chemistry|May 5, 2018
Discovery and Optimization of Indolyl-Containing 4-Hydroxy-2-Pyridone Type II DNA Topoisomerase Inhibitors Active against Multidrug Resistant Gram-negative BacteriaAleksey I Gerasyuto, Michael A Arnold, Jiashi Wang, et al.
Antimicrobial Agents and Chemotherapy|May 1, 2013
Identification of PTC725, an orally bioavailable small molecule that selectively targets the hepatitis C Virus NS4B proteinZhengxian Gu, Jason D Graci, Frederick C Lahser, et al.
Plos One|October 26, 2018
The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potentialWestley J Friesen, Briana Johnson, Jairo Sierra, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|December 15, 2015
Discovery of 2-(4-sulfonamidophenyl)-indole 3-carboxamides as potent and selective inhibitors with broad hepatitis C virus genotype activity targeting HCV NS4BNanjing Zhang, Anthony Turpoff, Xiaoyan Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2019
Effective Delivery of a Microtubule Polymerization Inhibitor Synergizes with Standard Regimens in Models of Pancreatic Ductal AdenocarcinomaJaime A Eberle-Singh, Irina Sagalovskiy, H Carlo Maurer, et al.
Human Molecular Genetics|August 9, 2021
SMN protein is required throughout life to prevent spinal muscular atrophy disease progressionXin Zhao, Zhihua Feng, Nicole Risher, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2015
6-(Azaindol-2-yl)pyridine-3-sulfonamides as potent and selective inhibitors targeting hepatitis C virus NS4BGuangming Chen, Hongyu Ren, Nanjing Zhang, et al.
Cancer Science|October 10, 2020
Efficacy of the novel tubulin polymerization inhibitor PTC-028 for myelodysplastic syndromeCheng Zhong, Kensuke Kayamori, Shuhei Koide, et al.
Plos One|December 20, 2016
Discovery of Novel Small Molecule Inhibitors of VEGF Expression in Tumor Cells Using a Cell-Based High Throughput Screening PlatformLiangxian Cao, Marla Weetall, Jenelle Bombard, et al.
Frontiers in Oncology|February 28, 2022
Emvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid LeukemiaArthur Branstrom, Liangxian Cao, Bansri Furia, et al.
Journal of Medicinal Chemistry|May 5, 2018
Discovery and Optimization of Indolyl-Containing 4-Hydroxy-2-Pyridone Type II DNA Topoisomerase Inhibitors Active against Multidrug Resistant Gram-negative BacteriaAleksey I Gerasyuto, Michael A Arnold, Jiashi Wang, et al.
Antimicrobial Agents and Chemotherapy|May 1, 2013
Identification of PTC725, an orally bioavailable small molecule that selectively targets the hepatitis C Virus NS4B proteinZhengxian Gu, Jason D Graci, Frederick C Lahser, et al.
Plos One|October 26, 2018
The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potentialWestley J Friesen, Briana Johnson, Jairo Sierra, et al.
Pageof 7